Wave Life Sciences
WVE
239 hedge funds and large institutions have $1.06B invested in Wave Life Sciences in 2026 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 100 increasing their positions, 54 reducing their positions, and 37 closing their positions.
113% more call options, than puts
Call options by funds: $3.23M | Put options by funds: $1.52M
85% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 54
35% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 37
3.2% more ownership
Funds ownership: 91.71% → 94.91% (+3.2%)
3% more funds holding
Funds holding: 232 → 239 (+7)
15% less capital invested
Capital invested by funds: $1.25B → $1.06B (-$189M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$33.7M |
| 2 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$31.3M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$17.4M |
| 4 |
Two Sigma Investments
New York
|
+$12.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$45.7M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$25.5M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$17.8M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$13.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.4M |
WVE Hedge Fund Activity: Q2 2026 in Review
239 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2026, worth a combined $1.06B — down 15% from $1.25B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new WVE positions and 37 closed out — a net gain of 13 holders — while 100 added to existing stakes and 54 trimmed.
The largest buyer was BlackRock, adding an estimated $33.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $45.7M.
- 239 institutional investors held Wave Life Sciences (WVE) as of Q2 2026, up from 232 in Q1 2026.
- Funds reported $1.06B of Wave Life Sciences stock for Q2 2026, down 15% quarter-over-quarter.
- 50 funds opened new Wave Life Sciences positions in Q2 2026 and 37 closed out, a net change of +13 holders.
- The largest Wave Life Sciences buyer in Q2 2026 was BlackRock, an estimated $33.7M added.
- The largest Wave Life Sciences seller in Q2 2026 was T. Rowe Price Associates, an estimated $45.7M sold.
Based on aggregated 13F filings for Q2 2026.